120 related articles for article (PubMed ID: 1653508)
1. ISCOM of BHV-1 envelope glycoproteins protected calves against both disease and infection.
Merza M; Tibor S; Kucsera L; Bognar G; Morein B
Zentralbl Veterinarmed B; 1991 Jun; 38(4):306-14. PubMed ID: 1653508
[TBL] [Abstract][Full Text] [Related]
2. Vaccination of calves against bovine herpesvirus-1: assessment of the protective value of eight vaccines.
Castrucci G; Frigeri F; Salvatori D; Ferrari M; Sardonini Q; Cassai E; Lo DM; Rotola A; Angelini R
Comp Immunol Microbiol Infect Dis; 2002 Jan; 25(1):29-41. PubMed ID: 11831745
[TBL] [Abstract][Full Text] [Related]
3. Efficacy of intranasal vaccination with a multivalent vaccine containing temperature-sensitive modified-live bovine herpesvirus type 1 for protection of seronegative and seropositive calves against respiratory disease.
Mahan SM; Sobecki B; Johnson J; Oien NL; Meinert TR; Verhelle S; Mattern SJ; Bowersock TL; Leyh RD
J Am Vet Med Assoc; 2016 Jun; 248(11):1280-6. PubMed ID: 27172345
[TBL] [Abstract][Full Text] [Related]
4. Bovine recombinant interleukin-2 augments immunity and resistance to bovine herpesvirus infection.
Reddy PG; Blecha F; Minocha HC; Anderson GA; Morrill JL; Fedorka-Cray PJ; Baker PE
Vet Immunol Immunopathol; 1989 Nov; 23(1-2):61-74. PubMed ID: 2559538
[TBL] [Abstract][Full Text] [Related]
5. Control of infectious bovine rhinotracheitis in calves with a BHV-1 subunit-ISCOM vaccine.
Trudel M; Boulay G; Séguin C; Nadon F; Lussier G
Vaccine; 1988 Dec; 6(6):525-9. PubMed ID: 3245294
[TBL] [Abstract][Full Text] [Related]
6. Efficacy of a combination viral vaccine for protection of cattle against experimental infection with field isolates of bovine herpesvirus-1.
Ellis JA; Gow SP; Goji N; Jones C; Workman A; Henderson G; Rhodes C; Alaniz G; Meinert TR; Tucker CM
J Am Vet Med Assoc; 2009 Sep; 235(5):563-72. PubMed ID: 19719449
[TBL] [Abstract][Full Text] [Related]
7. Vaccination to protect calves against infectious bovine rhinotracheitis.
Straub OC; Mawhinney IC
Vet Rec; 1988 Apr; 122(17):407-11. PubMed ID: 2839926
[TBL] [Abstract][Full Text] [Related]
8. Rapid onset of protection following vaccination of calves with multivalent vaccines containing modified-live or modified-live and killed BHV-1 is associated with virus-specific interferon gamma production.
Woolums AR; Siger L; Johnson S; Gallo G; Conlon J
Vaccine; 2003 Mar; 21(11-12):1158-64. PubMed ID: 12559793
[TBL] [Abstract][Full Text] [Related]
9. Vaccination with a gE-negative bovine herpesvirus type 1 vaccine confers insufficient protection to a bovine herpesvirus type 5 challenge.
Silva AD; Spilki FR; Franco AC; Esteves PA; Hübner SO; Driemeier D; Oliveira AP; Rijsewijk F; Roehe PM
Vaccine; 2006 Apr; 24(16):3313-20. PubMed ID: 16480790
[TBL] [Abstract][Full Text] [Related]
10. Protection of cattle from bovine herpesvirus type I (BHV-1) infection by immunization with individual viral glycoproteins.
Babiuk LA; L'Italien J; van Drunen Littel-van den Hurk S; Zamb T; Lawman JP; Hughes G; Gifford GA
Virology; 1987 Jul; 159(1):57-66. PubMed ID: 3037783
[TBL] [Abstract][Full Text] [Related]
11. Longevity of protective immunity to experimental bovine herpesvirus-1 infection following inoculation with a combination modified-live virus vaccine in beef calves.
Ellis J; Waldner C; Rhodes C; Ricketts V
J Am Vet Med Assoc; 2005 Jul; 227(1):123-8. PubMed ID: 16013547
[TBL] [Abstract][Full Text] [Related]
12. Latency and reactivation of a glycoprotein E negative bovine herpesvirus type 1 vaccine: influence of virus load and effect of specific maternal antibodies.
Lemaire M; Schynts F; Meyer G; Georgin JP; Baranowski E; Gabriel A; Ros C; Belák S; Thiry E
Vaccine; 2001 Sep; 19(32):4795-804. PubMed ID: 11535332
[TBL] [Abstract][Full Text] [Related]
13. Immunopotentiation of bovine respiratory disease virus vaccines by interleukin-1 beta and interleukin-2.
Reddy DN; Reddy PG; Xue W; Minocha HC; Daley MJ; Blecha F
Vet Immunol Immunopathol; 1993 Jun; 37(1):25-38. PubMed ID: 8393601
[TBL] [Abstract][Full Text] [Related]
14. Identification of a mutant bovine herpesvirus-1 (BHV-1) in post-arrival outbreaks of IBR in feedlot calves and protection with conventional vaccination.
van Drunen Littel-van den Hurk S; Myers D; Doig PA; Karvonen B; Habermehl M; Babiuk LA; Jelinski M; Van Donkersgoed J; Schlesinger K; Rinehart C
Can J Vet Res; 2001 Apr; 65(2):81-8. PubMed ID: 11346260
[TBL] [Abstract][Full Text] [Related]
15. A non-specific defence inducer in preventing clinical signs of infectious bovine rhinotracheitis in calves.
Castrucci G; Ferrari M; Osburn BI; Frigeri F; Barreca F; Tagliati S; Cuteri V
Comp Immunol Microbiol Infect Dis; 1996 Jun; 19(3):163-9. PubMed ID: 8800541
[TBL] [Abstract][Full Text] [Related]
16. Adjuvant effects of sulfolipo-cyclodextrin in a squalane-in-water and water-in-mineral oil emulsions for BHV-1 vaccines in cattle.
Romera SA; Hilgers LA; Puntel M; Zamorano PI; Alcon VL; Dus Santos MJ; Blanco Viera J; Borca MV; Sadir AM
Vaccine; 2000 Aug; 19(1):132-41. PubMed ID: 10924795
[TBL] [Abstract][Full Text] [Related]
17. Epitope specificity and protective efficacy of the bovine immune response to bovine herpesvirus-1 glycoprotein vaccines.
Israel BA; Marshall RL; Letchworth GJ
Vaccine; 1988 Aug; 6(4):349-56. PubMed ID: 2461006
[TBL] [Abstract][Full Text] [Related]
18. Effectiveness of a BHV-1/BEFV bivalent vaccine against bovine herpesvirus type 1 infection in cattle.
Chung YC; Shen HY; Cheng LT; Liu SS; Chu CY
Res Vet Sci; 2016 Dec; 109():161-165. PubMed ID: 27892866
[TBL] [Abstract][Full Text] [Related]
19. One year duration of immunity of the modified live bovine viral diarrhea virus type 1 and type 2 and bovine herpesvirus-1 fractions of Vista® Once SQ vaccine.
Purtle L; Mattick D; Schneider C; Smith L; Xue W; Trigo E
Vaccine; 2016 Mar; 34(13):1582-1588. PubMed ID: 26859238
[TBL] [Abstract][Full Text] [Related]
20. Modification of active immunization with live bovine herpesvirus 1 vaccine by passive viral antibody.
Patel JR; Shilleto RW
Vaccine; 2005 Jul; 23(31):4023-8. PubMed ID: 15916839
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]